Skip to content

Nasdaq · CIK 0001822479

SHC Sotera Health Co

Insider trading from SEC Form 4. Last filing Mar 10, 2026. Close $18.06 on Oct 9, 2026, +38% from the 52-week low and -8% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company

Price and insider trades, last year

SHCOct 9, 2026 · close 18.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Sotera Health Co, scored.

ScoreInsiderValueHoldingsPrice contextFiled
58ModerateWarburg Pincus & Co.
director, owner
sell
$229M
15,000,000 shares
-44%+50% from low-24% from high
58ModerateGtcr Investment Xi LLC
director, owner
sell
$153M
10,000,000 shares
-44%+50% from low-24% from high
85StrongMichael B. Petras Jr.
Chairman & CEO
sell
$12M
750,000 shares
-86%-
60NotableGtcr Investment Xi LLC
director, owner
sell
$106M
6,480,000 shares
-22%-
60NotableWarburg Pincus & Co.
director, owner
sell
$159M
9,720,000 shares
-22%-
60NotableWarburg Pincus & Co.
director, owner
sell
$159M
9,720,000 shares
-22%-
58ModerateWarburg Pincus & Co.
director, owner
sell
$282M
18,000,000 shares
-29%-
58ModerateGtcr Investment Xi LLC
director, owner
sell
$188M
12,000,000 shares
-29%-
58ModerateWarburg Pincus & Co.
director, owner
sell
$282M
18,000,000 shares
-29%-
60NotableWarburg Pincus & Co.
director, owner
sell
$181M
12,000,000 shares
-16%-
60NotableGtcr Investment Xi LLC
director, owner
sell
$121M
8,000,000 shares
-16%-
60NotableWarburg Pincus & Co.
director, owner
sell
$181M
12,000,000 shares
-16%-
65NotableMichael P Rutz
President of Sterigenics
sell
$2.1M
126,611 shares
-22%-

Transactions

The last 44 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 6, 2026Gtcr Investment Xi LLC
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-10,000,000$15.27$153M12,735,301Mar 10, 2026
Mar 6, 2026Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-15,000,000$15.27$229M19,102,952Mar 10, 2026
Mar 2, 2026Alexander Dimitrief
SVP, General Counsel and Sec.
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-7,941$15.91$126k326,784Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-6,046$15.91$96k183,556Mar 4, 2026
Mar 2, 2026Alexander Dimitrief
SVP, General Counsel and Sec.
MOption exercise
Common Stock
+16,816--343,600Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
MOption exercise
Common Stock
+17,937--201,493Mar 4, 2026
Mar 2, 2026Alexander Dimitrief
SVP, General Counsel and Sec.
FTax withholding
Common Stock
-23,619$15.91$376k319,981Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
FTax withholding
Common Stock
-23,988$15.91$382k177,505Mar 4, 2026
Mar 2, 2026Alexander Dimitrief
SVP, General Counsel and Sec.
MOption exercise
Performance RSUsderivative
-16,816--11,210Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
FTax withholding
Common Stock
-8,240$15.91$131k169,265Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
AGrant or award
Common Stock
+59,355$0.00$0228,620Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
MOption exercise
Performance RSUsderivative
-17,937--11,958Mar 4, 2026
Mar 2, 2026Jonathan M. Lyons
Sr. Vice President, CFO
AGrant or award
Performance RSUsderivative
+29,678$0.00$029,678Mar 4, 2026
Dec 8, 2025Michael B. Petras Jr.
Chairman & CEO
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")
-315,896$16.45$5.2M552,790Dec 10, 2025
Dec 8, 2025Michael B. Petras Jr.
Chairman & CEO
SOpen-market sale
Common Stockindirect: By Grantor Trust
-394,861$16.45$6.5M4,819,393Dec 10, 2025
Dec 8, 2025Michael B. Petras Jr.
Chairman & CEO
SOpen-market sale
Common Stockindirect: By Family Trust
-39,243$16.45$646k0Dec 10, 2025
Dec 3, 2025Gtcr Investment Xi LLC
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-6,480,000$16.33$106M22,735,301Dec 5, 2025
Dec 3, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-9,720,000$16.33$159M34,102,952Dec 5, 2025
Dec 3, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-9,720,000$16.33$159M34,102,952Dec 5, 2025
Nov 10, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-18,000,000$15.65$282M43,822,952Nov 12, 2025
Nov 10, 2025Gtcr Investment Xi LLC
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-12,000,000$15.65$188M29,215,301Nov 12, 2025
Nov 10, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-18,000,000$15.65$282M43,822,952Nov 12, 2025
Sep 5, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-12,000,000$15.11$181M61,822,952Sep 9, 2025
Sep 5, 2025Warburg Pincus & Co.
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-12,000,000$15.11$181M61,822,952Sep 9, 2025
Sep 5, 2025Gtcr Investment Xi LLC
director, owner
SOpen-market sale
Common Stock, $0.01 par value per share ("Common Stock")indirect: See Footnote
-8,000,000$15.11$121M41,215,301Sep 9, 2025
Aug 22, 2025Michael P Rutz
President of Sterigenics
SOpen-market sale
Common Stock
-126,611$16.38$2.1M450,204Aug 26, 2025
Aug 5, 2025Jonathan M. Lyons
Sr. Vice President, CFO
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-11,508$11.19$129k189,602Aug 7, 2025
May 22, 2025Vincent K Petrella
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$080,781May 27, 2025
May 22, 2025David E. Wheadon
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$074,912May 27, 2025
May 22, 2025Christopher Simon
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$019,132May 27, 2025
May 22, 2025James Neary
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$080,781May 27, 2025
May 22, 2025Constantine S Mihas
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$080,781May 27, 2025
May 22, 2025Robert Brown Knauss
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$054,933May 27, 2025
May 22, 2025Ann R. Klee
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$0125,956May 27, 2025
May 22, 2025Karen Flynn
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$039,221May 27, 2025
May 22, 2025Ruoxi Chen
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$080,781May 27, 2025
May 22, 2025Sean Laurence Cunningham
director
AGrant or award
Common Stock, $0.01 par value per share ("Common Stock")
+19,132$0.00$080,781May 27, 2025
Mar 2, 2025Alexander Dimitrief
SVP, General Counsel and Sec.
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-8,211$12.47$102k278,672Mar 4, 2025
Mar 3, 2025Alexander Dimitrief
SVP, General Counsel and Sec.
AGrant or award
Common Stock
+56,053$0.00$0334,725Mar 4, 2025
Mar 3, 2025Alexander Dimitrief
SVP, General Counsel and Sec.
AGrant or award
Performance RSUsderivative
+28,026$0.00$028,026Mar 4, 2025
Nov 20, 2024Michael B. Petras Jr.
Chairman & CEO
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-29,250$13.21$386k670,499Nov 22, 2024
Nov 20, 2024Michael P Rutz
President of Sterigenics
FTax withholding
Common Stock, $0.01 par value per share ("Common Stock")
-2,889$13.21$38k541,520Nov 22, 2024
Nov 22, 2024Michael B. Petras Jr.
Chairman & CEO
GGift
Common Stock, $0.01 par value per share ("Common Stock")indirect: By Grantor Trust
-39,243$0.00$05,214,337Nov 22, 2024
Nov 22, 2024Michael B. Petras Jr.
Chairman & CEO
GGift
Common Stock, $0.01 par value per share ("Common Stock")indirect: By Family Trust
+39,243$0.00$039,243Nov 22, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

SHC insider trading: Sotera Health Co | InsiderTell